United Health Products, Inc. (UEEC)
| Market Cap | 10.19M -55.9% |
| Revenue (ttm) | n/a |
| Net Income | -1.42M |
| EPS | -0.01 |
| Shares Out | 262.69M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 250 |
| Open | 0.0380 |
| Previous Close | 0.0390 |
| Day's Range | 0.0352 - 0.0380 |
| 52-Week Range | 0.0332 - 0.1200 |
| Beta | -0.26 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 21, 2026 |
About United Health Products
United Health Products, Inc. develops, manufactures, and markets hemostatic gauze products for the healthcare and wound care sectors in the United States. The company offers CelluSTAT hemostatic gauze products to absorb exudate/drainage from superficial wounds, as well as helps in controlling bleeding. It serves hospitals and surgery centers, clinics and physicians, military medical care providers, hemodialysis centers, nursing homes and assisted living, and veterinary hospitals; and EMS, fire departments, and other first responders, as well as... [Read more]
Financial Performance
Financial StatementsNews
United Health Products to Present at the Life Sciences Virtual Investor Forum September 18th
Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com Company invites individual and institutional investors, as ...
United Health Products provides update on clinical study process
United Health Products (UEEC) provided an update on the company’s planned clinical study. As previously disclosed, United Health Products is conducting a clinical trial of its CelluSTAT Hemostatic Gau...
United Health Products Provides Update on Clinical Study Process
MT. LAUREL, N.J., Dec. 02, 2024 (GLOBE NEWSWIRE) -- United Health Products, Inc. (OTCPK: UEEC) today provided an update on the company's planned clinical study.
United Health Products provides update on PMA application
United Health Products (UEEC) provided an update on the company’s FDA Premarket Approval application process. Following the company’s August 15, 2024 submission of its Submission Issue Request to the ...
United Health Products submits response letter to FDA
United Health Products provided an update on the company’s FDA Premarket Approval application process. Following the company’s March 21 submission of its PMA application and the FDA’s June 18 “Deficie...
United Health Products Submits Response Letter to FDA
MT. LAUREL, NJ, Aug. 19, 2024 (GLOBE NEWSWIRE) -- United Health Products, Inc. (OTCPK: UEEC) today provided an update on the company's FDA Premarket Approval (PMA) application process.
United Health Products submits full Premarket Approval application
United Health Products provided an update on the company’s FDA Premarket Approval application process. The company confirms that it has submitted via the FDA eSTAR portal its Premarket Approval applic...
United Health Products Submits Full FDA PMA Application
MOUNT LAUREL, NJ, March 21, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- United Health Products, Inc. (OTCPK: UEEC) today provided an update on the company's FDA Premarket Approval application process...
United Health Products to proceed with final drafting of PMA documentation
United Health Products reports on the receipt and review of final reports on product sterilization and stability testing for its hemostatic gauze. As previously disclosed, UHP has been working with…
United Health Products Reports on FDA Application Status
MESQUITE, NV, Jan. 19, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – United Health Products (UEEC) reports today on the receipt and review of final reports on product sterilization and stability testing...
The Medicare Gold Rush Is Slowing Down
UnitedHealth's disappointing outlook and the Humana sale talks intensify concerns that the Medicare Advantage business isn't what it once was.
United Health Products reports on product testing for FDA application
United Health Products provided an update on the company’s FDA Premarket Approval application process. Due to further unanticipated delays in testing performed by external service providers, the compa...
United Health Products Reports on Product Testing for FDA Application
MESQUITE, NV, Aug. 04, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – United Health Products, Inc. (OTCPK: UEEC) today provided an update on the company's FDA Premarket Approval application process.
United Health Products Reports on Progress in Product Testing
MESQUITE, NV, June 27, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – United Health Products, Inc. (OTCPK: UEEC) today provided an update on the company's FDA Premarket Approval application process.
United Health Products Reiterates Guidance on FDA PMA Application Process
MESQUITE, NV, June 07, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – United Health Products, Inc. (OTCPK: UEEC) today provided an update on the company's FDA Premarket Approval application process.
Dow Stocks To Trade In June
This long/short strategy is producing profitable results. Here is what to do now.
United Health Products reports anomalies from lab testing of HemoStyp samples
United Health Products provided an update on the company’s FDA Premarket Approval application process. As disclosed in a press release on January 31, 2023, UHP produced three batch lots of…
United Health Products Provides Update on FDA PMA Application Process
Mesquite, NV, March 29, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – United Health Products, Inc. (OTCPK: UEEC) today provided an update on the company's FDA Premarket Approval application process.
United Health Products Provides Update on FDA PMA Application and Amendment to White Lion Agreement
Mesquite, NV, Jan. 31, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- United Health Products, Inc. (OTCPK: UEEC), (UHP) today provided an update on the company's FDA Premarket Approval application pr...
United Health Products provides update on PMA application
United Health Products provided an update on the company’s FDA Premarket Approval application. UHP continues to advance its Premarket Approval application with the Food and Drug Administration. The co...
United Health Products Provides Update on Manufacturing and FDA PMA Application
MESQUITE, NV, Dec. 19, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – United Health Products, Inc. (OTCPK: UEEC), (UHP) today provided an update on the company's FDA Premarket Approval application.
United Health Products Provides Update on FDA PMA Application
Mesquite, NV, Nov. 28, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- United Health Products, Inc. (OTCPK: UEEC), (UHP) today provides an update on the company's FDA Premarket Approval application.
CNBC Stock World Cup: United Healthcare vs Johnson & Johnson and Netflix vs Disney — who wins?
Heading into the World Cup season, CNBC spoke to Chuck Lieberman of Advisors Capital Management on whether United Healthcare or Johnson & Johnson will give investors a greater total return over the ne...
United Health Products Announces Equity Financing Agreement and Provides Corporate Update
Mesquite, NV, Sept. 06, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- United Health Products, Inc. (OTCPK: UEEC), (UHP) today announced that it has entered into a common stock purchase agreement to sel...
United Health Products Announces Settlement of SEC Investigation
HENDERSON, NV, June 16, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – United Health Products, Inc. (OTCPK: UEEC) (UHP), today announced a final settlement of the SEC investigation initially reported by ...